Recent Advances and Future Directions in Clinical Management of Head and Neck Squamous Cell Carcinoma

by Jameel Muzaffar, Shahla Bari, Kedar Kirtane, Christine H. Chung
Published 2021-01-01

Hearing loss in inner ear and systemic autoimmune disease: A systematic review of post‐cochlear implantation outcomes

by Jonathan Lee, Kirsty Biggs, Jameel Muzaffar, Manohar Bance, Peter Monksfield
Published 2021-06-01

Corrigendum to “Acute Lymphoblastic Leukemia following Lenalidomide Maintenance for Multiple Myeloma: Two Cases with Unexpected Presentation and Good Prognostic Features”

by Abdullah M. Khan, Jameel Muzaffar, Hemant Murthy, John R. Wingard, Jan S. Moreb
Published 2019-01-01

Acute Lymphoblastic Leukemia following Lenalidomide Maintenance for Multiple Myeloma: Two Cases with Unexpected Presentation and Good Prognostic Features

by Abdullah M. Khan, Jameel Muzaffar, Hermant Murthy, John R. Wingard, Jan S. Moreb
Published 2018-01-01

Outcomes of Cochlear Implantation in Patients with Temporal Bone Trauma: A Systematic Review and Narrative Synthesis

by Michael Eastwood, Kirsty Biggs, Chris Metcalfe, Jameel Muzaffar, Peter Monksfield, Manohar Bance
Published 2021-03-01

Cochlear Implantation Outcomes in Patients with Mitochondrial Hearing Loss: A Systematic Review and Narrative Synthesis

by Nawal Zia, Yasmin Nikookam, Jameel Muzaffar, Peter Kullar, Peter Monksfield, Manohar Bance
Published 2021-01-01

Chordomas and chondrosarcomas of the skull base: treatment and outcome analysis in a consecutive case series of 24 patients

by Christopher Metcalfe, Jameel Muzaffar, Kevin Kulendra, Paul Sanghera, Simon Shaw, Amjad Shad, Natarajan Saravanappa, Alessandro Paluzzi, Shahzada Ahmed
Published 2021-03-01

Corrigendum to “Outcomes of Programmed Cell Death Protein 1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Inhibitor Therapy in HIV Patients with Advanced Cancer”

by Shahla Bari, Jameel Muzaffar, Austin Chan, Sanjay R. Jain, Ahmad M. Haider, Marjorie Adams Curry, Christopher J. Hostler
Published 2019-01-01

347 Clinical outcomes of ovarian cancer patients treated with ALKS 4230, a novel engineered cytokine, in combination with pembrolizumab: ARTISTRY-1 trial

by Lucy Gilbert, Jameel Muzaffar, David McDermott, Vamsidhar Velcheti, Anna Spreafico, Valentina Boni, Christopher Hoimes, Ira Winer, Seth Rosen, Quincy Chu, Olivier Dumas, Aman Chauhan, Arvind Chaudhry, Piotr Tomczak, Debora Bruno, Elizabeth Dorn, Jessicca Rege
Published 2020-11-01

287 Safety and antitumor activity of indoleamine 2,3-dioxygenase 1 (IDO-1) inhibitor KHK2455 in combination with anti-CCR4 monoclonal antibody mogamulizumab in patients with advanc...

by Yi Liu, Capucine Baldini, Jameel Muzaffar, David Hong, Olivier Rixe, Christophe Massard, Timothy Yap, Solmaz Sahebjam, Ursa Brown-Glaberman, Andreea Varga, Sergey Efuni, Barbara Kapelan, Eniola Ogunmefun, Tomonori Tayama, Henry Zhao, Denis Healy, Robert Latek, Daisuke Nakashima, Emrullah Yilmaz
Published 2020-11-01

Concurrent Cetuximab and Nivolumab as a Second-Line or beyond Treatment of Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results of Phase I/II St...

by Christine H. Chung, Marcelo Bonomi, Conor E. Steuer, Jiannong Li, Priyanka Bhateja, Matthew Johnson, Jude Masannat, Feifei Song, Juan C. Hernandez-Prera, Bruce M. Wenig, Helen Molina, Joaquim M. Farinhas, Caitlin P. McMullen, J. Trad Wadsworth, Krupal B. Patel, Julie A. Kish, Jameel Muzaffar, Kedar Kirtane, James W. Rocco, Michael J. Schell, Nabil F. Saba
Published 2021-03-01